<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35259179</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>3</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Characteristics and impact of Long Covid: Findings from an online survey.</ArticleTitle><Pagination><StartPage>e0264331</StartPage><MedlinePgn>e0264331</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0264331</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0264331</ELocationID><Abstract><AbstractText Label="BACKGROUND">Long Covid is a public health concern that needs defining, quantifying, and describing. We aimed to explore the initial and ongoing symptoms of Long Covid following SARS-CoV-2 infection and describe its impact on daily life.</AbstractText><AbstractText Label="METHODS">We collected self-reported data through an online survey using convenience non-probability sampling. The survey enrolled adults who reported lab-confirmed (PCR or antibody) or suspected COVID-19 who were not hospitalised in the first two weeks of illness. This analysis was restricted to those with self-reported Long Covid. Univariate comparisons between those with and without confirmed COVID-19 infection were carried out and agglomerative hierarchical clustering was used to identify specific symptom clusters, and their demographic and functional correlates.</AbstractText><AbstractText Label="RESULTS">We analysed data from 2550 participants with a median duration of illness of 7.6 months (interquartile range (IQR) 7.1-7.9). 26.5% reported lab-confirmation of infection. The mean age was 46.5 years (standard deviation 11 years) with 82.8% females and 79.9% of participants based in the UK. 89.5% described their health as good, very good or excellent before COVID-19. The most common initial symptoms that persisted were exhaustion, chest pressure/tightness, shortness of breath and headache. Cognitive dysfunction and palpitations became more prevalent later in the illness. Most participants described fluctuating (57.7%) or relapsing symptoms (17.6%). Physical activity, stress, and sleep disturbance commonly triggered symptoms. A third (32%) reported they were unable to live alone without any assistance at six weeks from start of illness. 16.9% reported being unable to work solely due to COVID-19 illness. 37.0% reported loss of income due to illness, and 64.4% said they were unable to perform usual activities/duties. Acute systems clustered broadly into two groups: a majority cluster (n = 2235, 88%) with cardiopulmonary predominant symptoms, and a minority cluster (n = 305, 12%) with multisystem symptoms. Similarly, ongoing symptoms broadly clustered in two groups; a majority cluster (n = 2243, 88.8%) exhibiting mainly cardiopulmonary, cognitive symptoms and exhaustion, and a minority cluster (n = 283, 11.2%) exhibiting more multisystem symptoms. Belonging to the more severe multisystem cluster was associated with more severe functional impact, lower income, younger age, being female, worse baseline health, and inadequate rest in the first two weeks of the illness, with no major differences in the cluster patterns when restricting analysis to the lab-confirmed subgroup.</AbstractText><AbstractText Label="CONCLUSION">This is an exploratory survey of Long Covid characteristics. Whilst this is a non-representative population sample, it highlights the heterogeneity of persistent symptoms, and the significant functional impact of prolonged illness following confirmed or suspected SARS-CoV-2 infection. To study prevalence, predictors and prognosis, research is needed in a representative population sample using standardised case definitions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ziauddeen</LastName><ForeName>Nida</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-8964-5029</Identifier><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Wessex, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurdasani</LastName><ForeName>Deepti</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hara</LastName><ForeName>Margaret E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Patient contributor, Long Covid Support: www.longcovid.org, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hastie</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Patient contributor, Long Covid Support: www.longcovid.org, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roderick</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Guiqing</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Science, University of Leicester, Leicester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alwan</LastName><ForeName>Nisreen A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Wessex, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/S003711/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S003711/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="N">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013312" MajorTopicYN="N">Stress, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no potentially competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>8</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35259179</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pii">PONE-D-21-14682</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nabavi N. Long covid: How to define it and how to manage it. BMJ. 2020;370. doi: 10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Social Science &amp; Medicine. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E, Callard F, Stras L, Melville-J&#xf3;hannesson B, Pope R, Alwan NA. Why the Patient-Made Term &#x201c;Long Covid&#x201d; is needed. Wellcome Open Res. 2020;5:224. doi: 10.12688/wellcomeopenres.16307.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16307.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, et al.. COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med. Published online December 8, 2020. doi: 10.7326/M20-5926</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al.. Long COVID in the Faroe Islands&#x2014;a longitudinal study among non-hospitalized patients. Clinical Infectious Diseases. 2020;(ciaa1792). doi: 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D, Boyton R. Confronting the pathophysiology of long covid. The BMJ. Published December 9, 2020. Accessed March 10, 2021. https://blogs.bmj.com/bmj/2020/12/09/confronting-the-pathophysiology-of-long-covid/</Citation></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al.. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. Published online July 27, 2020. doi: 10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Pinto MD, Borelli JL, et al.. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler: Looking for Clarity in the Haze of the Pandemic. medRxiv. Published online March 5, 2021:2021.03.03.21252086. doi: 10.1101/2021.03.03.21252086</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.03.21252086</ArticleId><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al.. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391. doi: 10.1136/bmjopen-2020-048391</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>del Rio C, Collins LF, Malani P. Long-term Health Consequences of COVID-19. JAMA. 2020;324(17):1723. doi: 10.1001/jama.2020.19719</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, et al.. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Services Research. 2020;20(1):1144. doi: 10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingstone T, Taylor AK, O&#x2019;Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the &#x201c;right&#x201d; GP: a qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4(5). doi: 10.3399/bjgpopen20X101143</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Technical Article: Updated Estimates of the Prevalence of Post-Acute Symptoms among People with Coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021</Citation></Reference><Reference><Citation>Coronavirus (COVID-19) Infection Survey, UK Statistical bulletins&#x2014;Office for National Statistics. Accessed December 18, 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/previousReleases</Citation></Reference><Reference><Citation>Bliddal S, Banasik K, Pedersen OB, et al.. Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients. Sci Rep. 2021;11(1):13153. doi: 10.1038/s41598-021-92045-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92045-x</ArticleId><ArticleId IdType="pmc">PMC8222239</ArticleId><ArticleId IdType="pubmed">34162913</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, et al.. Cerebral Micro-Structural Changes in COVID-19 Patients&#x2013;An MRI-based 3-month Follow-up Study. EClinicalMedicine. 2020;25. doi: 10.1016/j.eclinm.2020.100484</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AW, Shah AS, Johnston JC, Carlsten C, Ryerson CJ. Patient-reported outcome measures after COVID-19: a prospective cohort study. European Respiratory Journal. Published online January 1, 2020. doi: 10.1183/13993003.03276-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi L, Mescia F, Turner L, et al.. Early immune pathology and persistent dysregulation characterise severe COVID-19. medRxiv. Published online January 15, 2021:2021.01.11.20248765. doi: 10.1101/2021.01.11.20248765</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.11.20248765</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J, Padilla S, Fern&#xe1;ndez-Gonz&#xe1;lez M, et al.. Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study. J Clin Immunol. 2021;41(7):1490&#x2013;1501. doi: 10.1007/s10875-021-01083-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01083-7</ArticleId><ArticleId IdType="pmc">PMC8285689</ArticleId><ArticleId IdType="pubmed">34273064</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al.. Characterising long-term covid-19: a rapid living systematic review. medRxiv. Published online December 9, 2020:2020.12.08.20246025. doi: 10.1101/2020.12.08.20246025</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.08.20246025</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE. Accessed December 18, 2020. https://www.nice.org.uk/guidance/ng188</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA, Johnson L. Defining long COVID: Going back to the start. Med (N Y). 2021;2(5):501&#x2013;504. doi: 10.1016/j.medj.2021.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.003</ArticleId><ArticleId IdType="pmc">PMC7992371</ArticleId><ArticleId IdType="pubmed">33786465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacobucci G. Covid-19: Lack of capacity led to halting of community testing in March, admits deputy chief medical officer. BMJ. 2020;369:m1845. doi: 10.1136/bmj.m1845</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1845</ArticleId><ArticleId IdType="pubmed">32376638</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale: Application to Patients With Multiple Sclerosis and Systemic Lupus Erythematosus. Archives of Neurology. 1989;46(10):1121&#x2013;1123. doi: 10.1001/archneur.1989.00520460115022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJ a. M, Barco S, et al.. The Post-COVID-19 Functional Status (PCFS) Scale: a tool to measure functional status over time after COVID-19. European Respiratory Journal. Published online January 1, 2020. doi: 10.1183/13993003.01494&#x2013;2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494&#x2013;2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the Fatigue Severity Scale in a Swiss Cohort. Sleep. 2008;31(11):1601&#x2013;1607. doi: 10.1093/sleep/31.11.1601</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/31.11.1601</ArticleId><ArticleId IdType="pmc">PMC2579971</ArticleId><ArticleId IdType="pubmed">19014080</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021. Accessed April 12, 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021</Citation></Reference><Reference><Citation>Updated estimates of the prevalence of long COVID symptoms&#x2014;Office for National Statistics. Accessed February 16, 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/adhocs/12788updatedestimatesoftheprevalenceoflongcovidsymptoms</Citation></Reference><Reference><Citation>Miller TE, Beltran WFG, Bard AZ, et al.. Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital. The FASEB Journal. 2020;34(10):13877&#x2013;13884. doi: 10.1096/fj.202001700RR</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202001700RR</ArticleId><ArticleId IdType="pmc">PMC7461169</ArticleId><ArticleId IdType="pubmed">32856766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward H, Cooke GS, Atchison C, et al.. Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults. The Lancet Regional Health&#x2013;Europe. 2021;4. doi: 10.1016/j.lanepe.2021.100098</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100098</ArticleId><ArticleId IdType="pmc">PMC8088780</ArticleId><ArticleId IdType="pubmed">33969335</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellewell J, Russell TW, Matthews R, et al.. Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections. BMC Medicine. 2021;19(1):106. doi: 10.1186/s12916-021-01982-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01982-x</ArticleId><ArticleId IdType="pmc">PMC8075718</ArticleId><ArticleId IdType="pubmed">33902581</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. A negative COVID-19 test does not mean recovery. Nature. 2020;584(7820):170&#x2013;170. doi: 10.1038/d41586-020-02335-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02335-z</ArticleId><ArticleId IdType="pubmed">32782377</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. The teachings of Long COVID. Commun Med. 2021;1(1):1&#x2013;3. doi: 10.1038/s43856-021-00016-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-021-00016-0</ArticleId><ArticleId IdType="pmc">PMC9053272</ArticleId><ArticleId IdType="pubmed">35602198</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. The road to addressing Long Covid. Science. 2021;373(6554):491&#x2013;493. doi: 10.1126/science.abg7113</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg7113</ArticleId><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Energy Envelope and prevention: Dr David Strain interview https://t.co/0Y9qn9NLeW. @ABrokenBattery. Published February 25, 2021. Accessed March 20, 2021. https://twitter.com/ABrokenBattery/status/1365066849692635138</Citation></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Herck MV, Delbressine JM, et al.. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Research. 2020;6(4). doi: 10.1183/23120541.00542-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes AW, Machado FVC, Meys R, et al.. Care Dependency in Non-Hospitalized Patients with COVID-19. Journal of Clinical Medicine. 2020;9(9):2946. doi: 10.3390/jcm9092946</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092946</ArticleId><ArticleId IdType="pmc">PMC7564703</ArticleId><ArticleId IdType="pubmed">32932582</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Accessed October 15, 2021. https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>